JWJinjun Wu

Jinjun Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinjun Wu has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Competition Between PAR and RNA Polymers Shapes Distinct Phases of Stress Granule Assembly

    by Ugur Yurtsever, Cecile Mathieu, Youlin Xia, Jinjun Wu, Tapas Paul, Ozan Ozdemir, Hongrui Liu, James Messing, Charalampos G. Kalodimos, Anthony K. L. Leung, et al.

    Many RNA-binding proteins (RBPs) bind poly(ADP-ribose) (PAR) despite lacking canonical PAR-binding domains, but the molecular basis and functional consequences of this interaction remain unclear. Because PAR can bind arginine-rich and hydrophobic regions that can also bind RNA, we hypothesized that PAR and RNA compete for shared sites on RBPs to regulate their function. Here, using proteomic and biochemical approaches, we identify a broad population of RBPs for which PAR and RNA have competitive interaction. This group is enriched for stress granule-associated proteins, including G3BP1/2. In G3BP1, PAR and RNA compete for binding a common site in an intrinsically disordered region (IDR3) that also undergoes covalent ADP-ribosylation. PAR binding disrupts the autoinhibitory IDR1-IDR3 interaction, shifting G3BP1 toward an open conformation known to promote condensation. PAR promotes early steps in condensation, after which it is replaced by RNA in a subsequent maturation phase. These studies show that PAR and RNA occupy distinct temporal and functional windows during condensate assembly, revealing mechanisms whereby stress granules shape the pool of translatable mRNAs.

  • Open Access

    ASPL couples the assembly of stress granules with their VCP-mediated disassembly

    by Gautam Pareek, Dongfang Li, Bo Wang, Jinjun Wu, Brian D. Freibaum, Joseph L. Basalla, Tharun Selvam Mahendran, Anurag Singh, Amanda Nourse, Honghu Quan, et al.

    Stress granules (SGs) are dynamic RNA-protein assemblies that form in response to cellular stress and must be efficiently disassembled to restore normal cell function. Valosin-containing protein (VCP), an enzyme implicated in neurodegenerative diseases, is essential for SG disassembly, but whether and how this process is coordinated with SG assembly remains unclear. Here, we identify the VCP cofactor, Alveolar soft part sarcoma locus (ASPL) as a key regulator linking SG assembly and disassembly. ASPL promotes SG assembly by facilitating biomolecular condensation of Ras guanosine triphosphatase–activating protein-binding protein (G3BP) and stabilizing its interactions with other SG proteins. ASPL also facilitates phosphorylation and activation of VCP by UNC-51-like kinases 1 and 2 (ULK1/2), enabling G3BP extraction and efficient SG disassembly. Pathogenic VCP mutations that disrupt ASPL binding impair SG disassembly, a defect rescued by phosphomimetic mutations or ASPL depletion. Our findings suggest that disruptions in the ASPL-VCP interaction uncouple SG assembly and disassembly, representing a potential mechanism underlying VCP-associated neurodegenerative diseases.


  • Top Cited Papers
    Open Access

    Identification of small molecule inhibitors of G3BP-driven stress granule formation

    by Brian D. Freibaum, James Messing, Haruko Nakamura, Ugur Yurtsever, Jinjun Wu, Hong Joo Kim, Jeff Hixon, Rene Marc Lemieux, Jay Duffner, Walter Huynh, et al.

    Stress granule formation is triggered by the release of mRNAs from polysomes and is promoted by the action of the RNA-binding proteins G3BP1/2. Stress granules have been implicated in several disease states, including cancer and neurodegeneration. Consequently, compounds that limit stress granule formation or promote their dissolution have potential as both experimental tools and novel therapeutics. Herein, we describe two small molecules, G3BP inhibitor a and b (G3Ia and G3Ib), designed to bind to a specific pocket in G3BP1/2 that is targeted by viral inhibitors of G3BP1/2 function. In addition to disrupting the co-condensation of RNA, G3BP1, and caprin 1 in vitro, these compounds inhibit stress granule formation in cells treated prior to or concurrent with stress and dissolve pre-existing stress granules. These effects are consistent across multiple cell types and a variety of initiating stressors. Thus, these compounds represent powerful tools to probe the biology of stress granules and hold promise for therapeutic interventions designed to modulate stress granule formation.